ASSESSING THE SAFETY PROFILE OF COVID-19 VACCINES IN YOUNG INDIVIDUALS: A POST-VACCINATION ADR STUDY

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

JIJI K; MADHUSUDHAN A C; MANOJKUMAR S; AUSTIN ARUL RAJ P J; MANOJ V; GUNA D

ASSESSING THE SAFETY PROFILE OF COVID-19 VACCINES IN YOUNG INDIVIDUALS: A POST-VACCINATION ADR STUDY

Authors: JIJI K, MADHUSUDHAN A C, MANOJKUMAR S, AUSTIN ARUL RAJ P J, MANOJ V, GUNA D

Unique Paper ID: 182501
Volume: 12
Issue: 2
PageNo: 2181-2186

Keywords: Adverse Drug Reaction (ADR) COVID-19 Covaxin Covishield AEFI

Abstract:
The safety of COVID-19 vaccines, particularly in younger populations, is of significant public health interest due to potential adverse drug reactions (ADRs) post-vaccination. While vaccines like Covaxin and Covishield have been crucial in mitigating the spread of the virus, understanding the safety profile among college-aged individuals remains limited. This study aims to assess the safety profile of Covaxin and Covishield in a college population, with a focus on post-vaccination ADRs. Data were collected through a Google Forms survey distributed to college students, focusing on those vaccinated with Covaxin or Covishield. The survey captured demographic information, the type of vaccine received, and any experienced ADRs. Additionally, responses were collected from a small group of students who had not received the vaccine, to explore vaccine hesitancy. The analysis focused on the incidence and severity of ADRs, with specific attention to serious events such as myocarditis, pericarditis, and tachycardia. These study results provide insight to the healthcare providers on the importance of monitoring and reporting ADR associated with the drug. The objective of this study is to assess the safety profile of COVID-19 vaccines, specifically Covaxin and Covishield, in a college-aged population. By focusing on self-reported ADRs, this research aims to provide insights into the types and frequencies of reactions experienced by young adults following vaccination. Furthermore, the study seeks to address vaccine hesitancy observed among a small group of respondents who have not been vaccinated. Understanding the safety and hesitancy landscape is crucial for guiding public health strategies, particularly in efforts to increase vaccine confidence and improve coverage.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 12
Issue: 2
PageNo: 2181-2186

ASSESSING THE SAFETY PROFILE OF COVID-19 VACCINES IN YOUNG INDIVIDUALS: A POST-VACCINATION ADR STUDY

Available:https://ijirt.org/Article?manuscript=182501

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now